Experimental group:Carrelizumab and apatinib mesylate combined with radiotherapy

2 trials

Sponsors

The Affiliated Hospital of Youjiang Medical College, Affiliated Tumor Hospital of Guangxi Medical University

Conditions

CholangiocarcinomaStomach cancer

Phase 2

A single-arm, prospective clinical study of carrelizumab combined with apatinib and FOLFOX4 in the treatment of advanced unresectable cholangiocarcinoma

Active, not recruitingChiCTR2100048021

Affiliated Tumor Hospital of Guangxi Medical UniversityCholangiocarcinoma

Start: 2021-07-01Updated: 2022-03-07

A single-arm, prospective clinical study of carrelizumab combined with apatinib and SOX in the treatment of advanced unresectable gastric cancer

RecruitingChiCTR2100048020

The Affiliated Hospital of Youjiang Medical CollegeStomach cancer

Start: 2021-07-01Updated: 2022-08-16